What Is the AEHG ETF? A Complete Guide to Returns, Expense Ratio, Holdings and Alternative ETFs
The Leverage Shares 2X Long AEHR Daily ETF, or AEHG ETF, is a leveraged product that is highly sensitive to the short-term direction of Aehr Test Systems' share price. Investors should weigh the gap in cumulative performance caused by daily rebalancing, its volatility, and the outlook for related stocks.
What Is the Leverage Shares 2X Long AEHR Daily ETF?
The AEHG ETF is a single-stock leveraged ETF designed to track an amplified version of the daily moves in Aehr Test Systems' share price. Because the call on the underlying stock's direction feeds straight into performance, the approach differs from that of an index-based diversified ETF.
It suits investors who have a clear short-term trading plan, can monitor moves in the underlying stock often, and understand the loss risk built into a leveraged structure.
It is a passively managed (index-tracking) ETF run by Leverage Shares.
How Do You Invest in the Leverage Shares 2X Long AEHR Daily ETF?
| Item | Details |
|---|---|
| Tracked Asset | Aehr Test Systems share price |
| Management Style | Leveraged daily tracking |
| Rebalancing Frequency | Rebalanced daily |
| Distribution Frequency | No distribution history |
| Total Expense Ratio | 0.99% |
This product uses a derivatives structure that reflects Aehr Test Systems' one-day share price changes in an amplified direction. Because the target exposure is reset every day, the longer the holding period, the wider the gap can grow between the underlying stock's cumulative performance and the ETF's actual performance.
- Daily leveraged exposure concentrated in a single stock
- An exchange-listed structure that can be traded without a margin account
Leverage Shares 2X Long AEHR Daily ETF Size and Costs (AUM and Management Fee)
Assets under management (AUM) stand at $19.7M, and the total expense ratio is 0.99% per year.
As a micro-cap ETF, it is wise to check bid-ask spreads and order execution conditions before trading. The key is balancing daily exposure management and ease of trading rather than long-term holding costs.
Leverage Shares 2X Long AEHR Daily ETF Performance and Trends
The performance of a single-stock leveraged structure reacts sharply to the direction and magnitude of moves in Aehr Test Systems' share price. In an environment of repeated rises and falls, daily rebalancing and compounding effects accumulate, and the return path can diverge from that of the underlying stock.
Issues tied to semiconductor test equipment and shifting expectations for the company's earnings can affect the underlying stock, and trading demand for this product may swing accordingly. As a micro-cap ETF, it also requires checking market participants' order flow and liquidity conditions.
Leverage Shares 2X Long AEHR Daily ETF Pros and Cons
Its strength is amplified daily exposure when the directional call is right, but single-stock concentration and the effects of daily rebalancing make it a structure with significant risk for long-term holding.
💪 Key Strengths
⚠️ Points to Watch
Leverage Shares 2X Long AEHR Daily ETF Alternative ETFs and Related Products
The metadata provided does not include comparison products in the same category or verified additional alternatives. Therefore, we do not arbitrarily suggest specific ETFs outside the table. Because this product aims at daily directional exposure to a single stock, when comparing it with typical diversified ETFs or long-term holding products, investors should check the structural differences, focusing on underlying asset concentration, compounding effects from daily rebalancing, trading liquidity, and expense burden.
| Ticker | Name | Price | Change | AUM | Total Expense Ratio | Dividend Yield | 1Y |
|---|---|---|---|---|---|---|---|
| ProShares UltraPro QQQ 3x Shares | $62.01 | -10.5% | $35.8B | 0.78% | 0.78% | +7.8% | |
| Direxion Daily Semiconductor Bull 3X ETF | $77.05 | -24.8% | $24.4B | 0.75% | 0.12% | +62.6% | |
| ProShares Ultra QQQ 2x Shares | $82.59 | -6.9% | $14.2B | 0.89% | 0.15% | +11.6% | |
| ProShares Ultra S&P500 2x Shares | $67.67 | -3.6% | $8.8B | 0.84% | 0.7% | +16.6% | |
| Direxion Daily S&P 500 Bull 3X ETF | $270.35 | -5.4% | $7.1B | 0.84% | 0.54% | +21.6% |
| Ticker | Name | Weight | Price | Change | Market Cap | P/E | Dividend Yield |
|---|---|---|---|---|---|---|---|
| First American Financial Corp | 0.05% | $63.82 | +0.2% | $6.5B | 9.0 | 3.64% |
Leverage Shares 2X Long AEHR Daily ETF Investor Checkpoints
Before buying, understand this product as a short-term tactical tool rather than a long-term core asset. It is important to review together the direction of the underlying stock, the compounding effects of daily rebalancing, the trading conditions of a micro-cap ETF, and your own tolerance for losses.
| Checkpoint | What to Check | Current Status |
|---|---|---|
| Expense burden | Check how fees and trading costs affect short-term management | Needs checking |
| Trading conditions | Check bid-ask spreads and order execution feasibility in advance | Needs checking |
| Underlying stock volatility | Review Aehr Test Systems disclosures and industry changes | High volatility |
| Holding period | Understand the cumulative impact of daily rebalancing and compounding | Short-term management needed |
If the underlying stock moves against expectations, losses can be amplified, and even when the direction is right, repeated ups and downs can make the compounding effect of daily rebalancing work against you. As a micro-cap ETF, reduced liquidity and wide bid-ask spreads can also add an extra burden to actual trading results.
The AEHG ETF is built for investors who want to express a short-term directional view on Aehr Test Systems through a listed ETF structure. If your goal is long-term holding or stable distributions, you should re-examine its structural suitability, and before trading, it is best to check the underlying stock's volatility and execution conditions first.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. All investment responsibility lies with the investor.
This article reflects information as of August 18, 2026.